<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Neonatal herpes simplex virus infection: Clinical features and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Neonatal herpes simplex virus infection: Clinical features and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Neonatal herpes simplex virus infection: Clinical features and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gail J Demmler-Harrison, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 14, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Herpes simplex virus (HSV) infection during pregnancy poses a significant risk to the developing fetus and newborn. Neonates can acquire HSV infection by intrauterine, perinatal, or postnatal transmission of the virus; most cases are acquired perinatally. Neonatal HSV infection causes serious morbidity and mortality and leaves many survivors with permanent sequelae. Strong clinical suspicion, timely diagnosis, and early antiviral treatment are critical to improving outcome. </p><p>The clinical features and diagnosis of neonatal HSV infection will be reviewed here. The management, outcome, and prevention of neonatal HSV infection and genital HSV infection during pregnancy are discussed separately. (See  <a class="medical medical_review" href="/d/html/6040.html" rel="external">"Neonatal herpes simplex virus infection: Management and prevention"</a> and  <a class="medical medical_review" href="/d/html/8340.html" rel="external">"Genital herpes simplex virus infection and pregnancy"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">VIROLOGY</span><span class="headingEndMark"> — </span>HSV is a member of the Herpesviridae family of viruses. It contains a double-stranded linear deoxyribonucleic acid (DNA) genome that consists of 150,000 base pairs that encode for more than 80 polypeptides, a capsid consisting of 162 capsomeres arranged in icosahedral symmetry that is covered by a tightly adherent membranous tegument, and an envelope consisting of 11 glycoproteins (gB, gC, gD, gE, gG, gH, gI, gJ, gK, gL, and gM), lipids, and polyamines that surrounds the viral nucleocapsid  (<a class="graphic graphic_picture graphicRef81175" href="/d/graphic/81175.html" rel="external">picture 1</a>) [<a href="#rid1">1</a>]. Like all <em>Herpesviridae</em> viruses, HSV shares the biologic properties of latency and reactivation, which causes recurrent infections in the host.</p><p>HSV enters the human host through inoculation of oral, genital, nasal, or conjunctival mucosa or breaks in skin, then infects the sensory nerve endings, and then transports via retrograde axonal flow to the dorsal root ganglia, where it remains for the life of the host. The fetus may be infected transplacentally or through retrograde spread through ruptured or seemingly intact membranes [<a href="#rid1">1</a>]. Latent virus is not susceptible to antiviral drugs, and infection (even after antiviral therapy) is lifelong. (See  <a class="medical medical_review" href="/d/html/6040.html" rel="external">"Neonatal herpes simplex virus infection: Management and prevention", section on 'Outcome'</a>.)</p><p>HSV replicates efficiently in cell cultures, quickly producing lytic cytopathic effect in one to three days in most cell lines used in virology laboratories  (<a class="graphic graphic_picture graphicRef72209" href="/d/graphic/72209.html" rel="external">picture 2</a>). The virus can be typed into HSV type 1 and HSV type 2 using serologic and molecular techniques. The DNA of HSV-1 and HSV-2 contain many homologous sequences distributed over the entire genome of both types, which produce both unique (gG) and antigenically similar polypeptides [<a href="#rid1">1</a>]. This cross-reactivity between HSV-1 and HSV-2 glycoproteins is the reason many commercially available serologic assays cannot reliably distinguish between HSV-1 and HSV-2 antibodies. Diversity in genes encoding certain viral proteins may correlate with clinical disease manifestations in the neonate. In particular, genes that impact neurovirulence and viral spread between cells (eg, glycoprotein G [gG; US4], I [GI; US7], and K [GK; UL53], and viral proteins UL8, UL20, UL24, and US2) have been associated with more severe neuroinvasive disease in preliminary studies [<a href="#rid2">2</a>]. </p><p class="headingAnchor" id="H3"><span class="h1">EPIDEMIOLOGY AND TRANSMISSION</span></p><p class="headingAnchor" id="H2638133238"><span class="h2">Incidence and prevalence</span><span class="headingEndMark"> — </span>The estimated incidence of neonatal HSV infection ranges from 3 to 30 per 100,000 live births [<a href="#rid3">3-8</a>]. The wide variation is likely due to differences in the prevalence of genital herpes in different areas around the world and differences in reporting practices. In the United States, the annual incidence is approximately 8 to 10 cases per 100,000 live births [<a href="#rid3">3,8</a>]. Globally, there are an estimated 14,000 cases of neonatal HSV infection per year [<a href="#rid9">9</a>].</p><p>The prevalence of HSV among young infants presenting to an emergency department setting with signs of central nervous system (CNS) infection was investigated in a multicenter retrospective study of &gt;25,000 infants &lt;60 days old (median age 28 days) who underwent lumbar puncture for evaluation of fever or other clinical concern [<a href="#rid10">10</a>]. Testing for HSV was performed in 35 percent of patients. HSV infection was identified in 1.2 percent of infants tested (0.4 percent of the entire cohort), 39 percent of whom had skin, eye, and mouth (SEM) disease, 32 percent of whom had CNS disease, and 29 percent of whom had disseminated disease. HSV prevalence peaked in the second week of life and declined substantially in the second month of life. Despite the low prevalence of HSV in this setting, testing and empiric treatment for HSV are often warranted in ill-appearing febrile neonates because early treatment has been shown to improve survival and reduce long-term sequelae. This issue is discussed briefly below and is reviewed in greater detail separately. (See <a class="local">'Clinical suspicion'</a> below and  <a class="medical medical_review" href="/d/html/6040.html" rel="external">"Neonatal herpes simplex virus infection: Management and prevention", section on 'Initial antiviral therapy'</a> and  <a class="medical medical_review" href="/d/html/106744.html" rel="external">"The febrile infant (29 to 90 days of age): Management", section on 'Herpes simplex virus'</a> and  <a class="medical medical_review" href="/d/html/134347.html" rel="external">"The febrile neonate (28 days of age or younger): Outpatient evaluation and initial management", section on 'Herpes simplex virus infection'</a>.) </p><p class="headingAnchor" id="H3885273588"><span class="h2">Trends over time</span><span class="headingEndMark"> — </span>The incidence of neonatal HSV disease appears to have modestly increased since the early 2000s [<a href="#rid8">8</a>]. One reason for this is that the prevalence of genital HSV infection appears to be increasing in the general population. In particular, HSV-1 genital infection among adolescents and young adults (AYAs) appears to be increasing, and thus neonatal HSV-1 infection may be increasing [<a href="#rid9">9</a>]. The result is that a greater proportion of neonatal HSV disease in the contemporary era is due to HSV-1 rather than HSV-2. Neonates with HSV-1 disease are more likely to present with SEM disease, whereas HSV-2 disease is more commonly associated with CNS disease [<a href="#rid9">9,11</a>]. (See  <a class="medical medical_review" href="/d/html/8347.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection", section on 'Epidemiology'</a>.) </p><p>The evolving epidemiology of neonatal HSV disease was described in a single-center study from 1980 to 2016 [<a href="#rid9">9</a>]. The following changes were observed over the course of the study:</p><p class="bulletIndent1"><span class="glyph">●</span>Beginning in 2010, HSV-1 eclipsed HSV-2 as being the more common viral type for neonatal infection</p><p class="bulletIndent1"><span class="glyph">●</span>Since 2010, more infants presented with SEM disease; whereas before 2010, most affected neonates presented with CNS or disseminated disease</p><p class="bulletIndent1"><span class="glyph">●</span>The average time from onset of symptoms to diagnosis and initiation of treatment decreased from approximately 6 to 8 days in the earlier eras to approximately 3 to 4 days in the contemporary era</p><p class="bulletIndent1"><span class="glyph">●</span>Mortality decreased from approximately 20 percent in the earlier eras to 5 percent in the contemporary era</p><p></p><p class="headingAnchor" id="H3386666725"><span class="h2">Transmission</span><span class="headingEndMark"> — </span>Neonatal HSV has three distinct periods of acquisition: intrauterine, perinatal, and postnatal.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intrauterine</strong> – Approximately 5 percent of neonatal HSV infections are caused by intrauterine infection. Viral infection occurs in the fetus before birth and disease manifestations are present at birth. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Perinatal</strong> – The majority (85 percent) of neonatal HSV infections are acquired perinatally [<a href="#rid12">12</a>]. HSV is acquired perinatally when HSV infection, either symptomatic or asymptomatic, is present in the genital tract of the pregnant woman at the time of delivery. </p><p></p><p class="bulletIndent1">Factors that may influence perinatal transmission include [<a href="#rid13">13</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Type of maternal HSV infection (primary maternal HSV infection is associated with higher risk of transmission to the neonate compared with recurrent)</p><p class="bulletIndent2"><span class="glyph">•</span>Maternal HSV antibody status</p><p class="bulletIndent2"><span class="glyph">•</span>Duration of ruptured membranes</p><p class="bulletIndent2"><span class="glyph">•</span>Use of fetal scalp monitors</p><p class="bulletIndent2"><span class="glyph">•</span>Mode of delivery (cesarean versus vaginal, although neonates born via cesarean may still develop neonatal HSV disease)  </p><p></p><p class="bulletIndent1">However, most neonates with HSV disease are born to mothers without a history of HSV infection or other identifiable risk factors [<a href="#rid14">14</a>]. Maternal fever is a risk factor for neonatal HSV infection [<a href="#rid14">14-19</a>]. (See  <a class="medical medical_review" href="/d/html/8340.html" rel="external">"Genital herpes simplex virus infection and pregnancy", section on 'Vertical transmission'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postnatal</strong> – Approximately 10 percent of neonatal HSV infections are acquired postnatally [<a href="#rid12">12</a>]. Postnatal acquisition of neonatal HSV occurs from direct contact with a family member or other close contact with active HSV infection, such as herpes labialis [<a href="#rid20">20,21</a>]. There are isolated case reports of sibling transmission when one sibling has gingivostomatitis and kisses or bites the newborn [<a href="#rid20">20</a>]. Postnatally acquired HSV infection can be especially severe in newborns born to women without prior HSV infection [<a href="#rid20">20</a>]. This is because such newborns will not have received transplacental transmission of HSV-specific antibody.</p><p></p><p class="headingAnchor" id="H4"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H5"><span class="h2">Intrauterine HSV</span><span class="headingEndMark"> — </span>Intrauterine or congenital HSV infection is rare and results from either maternal viremia associated with primary HSV infection during pregnancy or ascending infection:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intrauterine infection due to maternal primary infection</strong> – Intrauterine infection that results from maternal primary HSV infection and viremia during pregnancy is associated with placental infarcts; necrotizing, calcifying funisitis (inflammation of the umbilical cord); plasma cell deciduitis; lymphoplasmacytic villitis  (<a class="graphic graphic_picture graphicRef52458" href="/d/graphic/52458.html" rel="external">picture 3</a>); hydrops fetalis; and fetal in utero demise. Demonstration of the virus in placenta tissue by immunohistochemistry or by molecular techniques is necessary for diagnosis of HSV involvement of the placenta because other placental findings are nonspecific. (See  <a class="medical medical_review" href="/d/html/6794.html" rel="external">"Nonimmune hydrops fetalis"</a> and  <a class="medical medical_review" href="/d/html/6827.html" rel="external">"Stillbirth: Incidence, risk factors, etiology, and prevention"</a>.)</p><p></p><p class="bulletIndent1">Liveborn neonates with intrauterine HSV infection may exhibit a characteristic triad of [<a href="#rid22">22-25</a>]: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Skin vesicles, ulcerations, or scarring  (<a class="graphic graphic_picture graphicRef55645" href="/d/graphic/55645.html" rel="external">picture 4</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Eye damage</p><p class="bulletIndent2"><span class="glyph">•</span>Severe central nervous system (CNS) manifestations, including microcephaly, cystic encephalomalacia, or hydranencephaly</p><p></p><p class="bulletIndent1">However, the characteristic triad occurs in less than one-third of cases, and a high index of suspicion is necessary to make the diagnosis [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intrauterine infection due to ascending infection</strong> – In utero congenital HSV infection from ascending infection usually occurs after prolonged rupture of membranes in mothers with active HSV infection near the time of delivery. Ascending transplacental infection of the fetus through intact amniotic membranes may also occur, and neonatal HSV infection has been documented after cesarean section in mothers with intact amniotic membranes [<a href="#rid26">26,27</a>]. The clinical presentation of newborns with intrauterine HSV acquired by ascending infection may be mild, with only cutaneous skin lesions or cutaneous scarring present, to severe, with signs and symptoms of disseminated HSV disease and fatal neonatal pneumonitis [<a href="#rid28">28,29</a>].</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Neonatal HSV</span><span class="headingEndMark"> — </span>Perinatally and postnatally acquired neonatal HSV may be classified into three main categories for therapeutic and prognostic purposes  (<a class="graphic graphic_table graphicRef106132" href="/d/graphic/106132.html" rel="external">table 1</a>): </p><p class="bulletIndent1"><span class="glyph">●</span>Localized skin, eye, and mouth (SEM) disease only (see <a class="local">'Skin, eye, and mouth disease'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>CNS disease (with or without SEM) (see <a class="local">'Central nervous system disease'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Disseminated disease (see <a class="local">'Disseminated disease'</a> below) </p><p></p><p>There is some overlap in these categories  (<a class="graphic graphic_figure graphicRef67814" href="/d/graphic/67814.html" rel="external">figure 1</a>). For example, disseminated HSV disease may have SEM and/or CNS involvement in addition to other organs, and SEM disease may progress to CNS or disseminated disease if not treated early. Both HSV-1 and HSV-2 may cause SEM, CNS, or disseminated disease; however, HSV-1 is more likely to be associated with SEM disease, while HSV-2 is associated more often with CNS disease and with a poorer outcome [<a href="#rid1">1,9,13,15,30</a>]. (See  <a class="medical medical_review" href="/d/html/6040.html" rel="external">"Neonatal herpes simplex virus infection: Management and prevention", section on 'Outcome'</a>.)</p><p class="headingAnchor" id="H7"><span class="h3">Skin, eye, and mouth disease</span><span class="headingEndMark"> — </span>SEM disease accounts for approximately 35 to 45 percent of neonatal HSV [<a href="#rid6">6,9</a>]. Neonatal HSV SEM disease may appear benign at onset of illness but is associated with a high risk of progression to CNS or disseminated disease if not treated. SEM disease usually presents in the first two weeks of life but may occur at any time during the first six weeks of life [<a href="#rid31">31</a>].</p><p>Localized skin disease is associated with coalescing or clustering vesicular lesions with an erythematous base  (<a class="graphic graphic_picture graphicRef75059" href="/d/graphic/75059.html" rel="external">picture 5C</a>) [<a href="#rid1">1</a>]. Vesicles may begin or cluster at the presenting part of the body, or at sites of localized trauma, such as scalp monitor sites  (<a class="graphic graphic_picture graphicRef56041" href="/d/graphic/56041.html" rel="external">picture 5B</a>). Skin vesicles also may appear late in the course of disseminated disease.</p><p>HSV infection of the eye may initially appear asymptomatic. In the neonate, early signs include excessive watering of the eye, crying from apparent eye pain, and conjunctival erythema  (<a class="graphic graphic_picture graphicRef78598" href="/d/graphic/78598.html" rel="external">picture 5A</a>). Periorbital skin vesicles may or may not be present at the time of presentation. HSV keratoconjunctivitis may progress to corneal scarring, cataracts, and chorioretinitis and result in permanent vision impairment [<a href="#rid1">1,22</a>].</p><p>HSV infection of the oropharynx may initially be asymptomatic but also may be characterized by localized ulcerative lesions of the mouth, palate, and tongue. It should be differentiated from other causes of oral lesions in the newborn such as local trauma or other viral infections (eg, enterovirus). (See  <a class="medical medical_review" href="/d/html/6282.html" rel="external">"Soft tissue lesions of the oral cavity in children", section on 'Infections'</a> and  <a class="medical medical_review" href="/d/html/6282.html" rel="external">"Soft tissue lesions of the oral cavity in children"</a>.)</p><p>Neonates and infants up to six weeks of age with evidence of SEM disease should undergo a thorough evaluation for CNS and disseminated disease. Infants with SEM disease may have associated HSV viremia. However, if there is no evidence systemic disease (eg, no liver, lung, kidney, cardiovascular, or CNS involvement), most experts would not consider such infants as having disseminated HSV disease. If SEM disease is treated early, before CNS or disseminated disease occurs, the outcome is favorable. (See <a class="local">'Detection of HSV'</a> below and <a class="local">'Laboratory evaluation'</a> below and  <a class="medical medical_review" href="/d/html/6040.html" rel="external">"Neonatal herpes simplex virus infection: Management and prevention", section on 'Outcome'</a>.)</p><p class="headingAnchor" id="H8"><span class="h3">Central nervous system disease</span><span class="headingEndMark"> — </span>Approximately one-third of neonatal HSV disease involves the CNS [<a href="#rid9">9,31</a>]. It may occur as a result of localized retrograde spread from the nasopharynx and olfactory nerves to the brain or through hematogenous spread in neonates with disseminated disease. Neonatal HSV CNS disease (also called neonatal HSV meningoencephalitis) usually presents in the second or third week of life, but may occur at any time during the first six weeks of life [<a href="#rid31">31</a>]. CNS disease may occur with or without SEM involvement and with or without disseminated disease. Between 60 and 70 percent of neonates with HSV CNS disease have skin vesicles at some point during the disease course [<a href="#rid12">12</a>].</p><p>Clinical manifestations of neonatal HSV CNS disease include seizures (focal or generalized), lethargy, irritability, tremors, poor feeding, temperature instability, and full anterior fontanel [<a href="#rid30">30,32,33</a>]. Early in the course of HSV CNS disease, none of these signs or symptoms may be apparent.</p><p>Cerebrospinal fluid (CSF) analysis in neonates with HSV CNS disease classically shows a modest mononuclear cell pleocytosis, normal or moderately low glucose concentration, and mildly elevated protein; however, CSF studies may be normal early in the course of the illness. Abnormalities of the CSF may be more pronounced as CNS disease progresses. Red blood cells are not significantly associated with neonatal HSV CNS disease and are more likely to be caused by an apparent "bloody tap" [<a href="#rid14">14</a>].</p><p>The electroencephalogram (EEG) often is abnormal very early in the course of CNS disease and may show lateralized periodic discharges (LPDs, previously called periodic epileptiform discharges [PLEDS]) [<a href="#rid1">1,34</a>]. (See <a class="local">'Electroencephalogram'</a> below.)</p><p>Computed tomography (CT) and magnetic resonance imaging (MRI) of the brain may be normal early in the course of CNS disease. Several days to a week into illness, neuroimaging studies may show parenchymal brain edema or attenuation, hemorrhage, or destructive lesions involving the temporal, frontal, parietal, or brainstem regions of the brain  (<a class="graphic graphic_diagnosticimage graphicRef64607" href="/d/graphic/64607.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef106590" href="/d/graphic/106590.html" rel="external">image 2</a>) [<a href="#rid1">1,32</a>]. (See <a class="local">'Diagnostic imaging'</a> below.)</p><p>In the absence of vesicles, the initial presentation of HSV CNS disease may be indistinguishable from other causes of neonatal sepsis or meningitis [<a href="#rid12">12,35</a>]. Many experts recommend evaluation for HSV CNS disease with HSV DNA polymerase chain reaction (PCR) and other CSF studies (ie, cell counts, protein, and glucose), and empiric treatment with <a class="drug drug_pediatric" data-topicid="13247" href="/d/drug information/13247.html" rel="external">acyclovir</a> in all neonates with aseptic meningitis or other signs and symptoms of meningoencephalitis without an obvious bacterial cause [<a href="#rid36">36,37</a>]. (See <a class="local">'Laboratory evaluation'</a> below and  <a class="medical medical_review" href="/d/html/6040.html" rel="external">"Neonatal herpes simplex virus infection: Management and prevention", section on 'Initial antiviral therapy'</a>.)</p><p>Neonates with certain underlying primary immune disorders (eg, functional natural killer [NK] cell deficiencies, toll-like receptor deficiencies) are at risk for developing severe HSV encephalitis and postinfectious complications such as HSV-mediated autoimmune encephalitis [<a href="#rid38">38</a>]. (See  <a class="medical medical_review" href="/d/html/3949.html" rel="external">"NK cell deficiency syndromes: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/3985.html" rel="external">"Toll-like receptors: Roles in disease and therapy", section on 'UNC93B1 deficiency, TLR3 mutations, TRIF deficiency, TRAF3 deficiency, and TBK1 deficiency'</a>.)</p><p class="headingAnchor" id="H9"><span class="h3">Disseminated disease</span><span class="headingEndMark"> — </span>Approximately 25 to 30 percent of neonatal HSV disease is the disseminated form, which is sepsis-like presentation, involving multiple organs [<a href="#rid9">9,19,31</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Liver  (<a class="graphic graphic_picture graphicRef53519" href="/d/graphic/53519.html" rel="external">picture 6</a> and <a class="graphic graphic_picture graphicRef61272" href="/d/graphic/61272.html" rel="external">picture 7</a>), including hepatitis with elevated liver transaminases, ascites, and direct hyperbilirubinemia that can progress to liver failure requiring liver transplantation [<a href="#rid39">39</a>]. (See  <a class="medical medical_review" href="/d/html/16142.html" rel="external">"Acute liver failure in children: Etiology and evaluation"</a> and  <a class="medical medical_review" href="/d/html/83172.html" rel="external">"Acute liver failure in children: Management, complications, and outcomes"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lungs  (<a class="graphic graphic_picture graphicRef63300" href="/d/graphic/63300.html" rel="external">picture 8</a>), including progressive interstitial pneumonitis and hemorrhagic pneumonitis, with or without effusion, that can progress to respiratory failure, requiring mechanical ventilation or extracorporeal life support [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CNS, which is involved in 60 to 75 percent of cases, usually through a hematogenously acquired meningoencephalitis [<a href="#rid31">31</a>]. (See <a class="local">'Central nervous system disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Heart, including myocarditis and myocardial dysfunction in severe disseminated neonatal HSV.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Adrenal glands  (<a class="graphic graphic_picture graphicRef52818" href="/d/graphic/52818.html" rel="external">picture 9</a> and <a class="graphic graphic_picture graphicRef61272" href="/d/graphic/61272.html" rel="external">picture 7</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bone marrow and coagulation system, including disseminated intravascular coagulation (DIC), thrombocytopenia, and neutropenia. (See  <a class="medical medical_review" href="/d/html/5915.html" rel="external">"Disseminated intravascular coagulation in infants and children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Kidneys. (See  <a class="medical medical_review" href="/d/html/4989.html" rel="external">"Neonatal acute kidney injury: Pathogenesis, etiology, clinical presentation, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gastrointestinal tract, including necrotizing enterocolitis. (See  <a class="medical medical_review" href="/d/html/5019.html" rel="external">"Neonatal necrotizing enterocolitis: Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Skin and mucous membranes lesions, which may appear late in the course of disseminated HSV disease; however, 20 to 40 percent of neonates with disseminated HSV disease do not have vesicles [<a href="#rid12">12</a>]. (See <a class="local">'Skin, eye, and mouth disease'</a> above.)</p><p></p><p>Neonates with disseminated HSV often present in the first week of life with nonspecific signs and symptoms of neonatal sepsis, including temperature dysregulation (fever or hypothermia), apnea, irritability, lethargy, respiratory distress, abdominal distension, hepatomegaly, and ascites [<a href="#rid1">1,19</a>]. Rarely, neonates with HSV infection may present with fever alone [<a href="#rid41">41</a>]. In advanced disseminated neonatal HSV disease, fever is often absent, and hypothermia is more prominent [<a href="#rid1">1,19</a>].</p><p>The diagnosis of disseminated neonatal HSV disease often is delayed until the second week of life, awaiting the results of evaluation for bacterial sepsis. In treated infants, the risk of mortality associated with disseminated HSV infection is approximately 40 to 50 percent; in untreated infants, mortality exceeds 80 percent [<a href="#rid9">9</a>]. Unfortunately, the diagnosis is sometimes made or confirmed at autopsy, after extensive organ damage has occurred  (<a class="graphic graphic_picture graphicRef61272" href="/d/graphic/61272.html" rel="external">picture 7</a> and <a class="graphic graphic_picture graphicRef53519" href="/d/graphic/53519.html" rel="external">picture 6</a> and <a class="graphic graphic_picture graphicRef63300" href="/d/graphic/63300.html" rel="external">picture 8</a> and <a class="graphic graphic_picture graphicRef52818" href="/d/graphic/52818.html" rel="external">picture 9</a>). Efforts are focused on identifying high-risk neonates with a sepsis-like picture, meningoencephalitis, progressive pneumonitis, or hepatitis, who should undergo testing for HSV and empiric antiviral therapy [<a href="#rid14">14,18,42,43</a>]. (See <a class="local">'Evaluation and diagnosis'</a> below and  <a class="medical medical_review" href="/d/html/6040.html" rel="external">"Neonatal herpes simplex virus infection: Management and prevention", section on 'Initial antiviral therapy'</a>.)</p><p class="headingAnchor" id="H11"><span class="h1">EVALUATION AND DIAGNOSIS</span></p><p class="headingAnchor" id="H12"><span class="h2">Overview</span><span class="headingEndMark"> — </span>Neonatal HSV infection is clinically challenging. Early manifestations may be subtle and nonspecific. Neonatal HSV can mimic other diseases, including bacterial illnesses (sepsis or meningitis), other viral illnesses (particularly enterovirus), and genetic/metabolic disorders of infancy. Prompt treatment requires early consideration of neonatal HSV as a possibility in neonates with mucocutaneous lesions, central nervous system (CNS) abnormalities, a sepsis-like picture, progressive hepatitis, or coagulopathy. (See <a class="local">'Differential diagnosis'</a> below and  <a class="medical medical_review" href="/d/html/6040.html" rel="external">"Neonatal herpes simplex virus infection: Management and prevention", section on 'Initial antiviral therapy'</a>.)</p><p class="headingAnchor" id="H13"><span class="h2">Clinical suspicion</span><span class="headingEndMark"> — </span>Neonatal HSV infection should be suspected in neonates and infants up to six weeks of age with [<a href="#rid31">31,44</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Mucocutaneous vesicles or ulcers  (<a class="graphic graphic_picture graphicRef78598 graphicRef56041 graphicRef75059" href="/d/graphic/78598.html" rel="external">picture 5A-C</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Sepsis-like illness (fever or hypothermia, irritability, lethargy, respiratory distress, apnea, abdominal distension, hepatomegaly, ascites, coagulopathy)</p><p class="bulletIndent1"><span class="glyph">●</span>Cerebrospinal fluid (CSF) pleocytosis, especially with a mononuclear predominance</p><p class="bulletIndent1"><span class="glyph">●</span>Seizures</p><p class="bulletIndent1"><span class="glyph">●</span>Focal neurologic signs</p><p class="bulletIndent1"><span class="glyph">●</span>Abnormal neuroimaging</p><p class="bulletIndent1"><span class="glyph">●</span>Respiratory distress, apnea, or progressive pneumonitis</p><p class="bulletIndent1"><span class="glyph">●</span>Thrombocytopenia</p><p class="bulletIndent1"><span class="glyph">●</span>Elevated liver transaminases, viral hepatitis, or acute liver failure</p><p class="bulletIndent1"><span class="glyph">●</span>Conjunctivitis, with watery discharge, excessive tearing, or painful eye symptoms, especially if unilateral</p><p></p><p>Early in the clinical course, some neonates with HSV infection may present with persistent fever and negative bacterial cultures.</p><p>Neonatal HSV infection remains a possibility in infants born to mothers who received suppressive <a class="drug drug_pediatric" data-topicid="13247" href="/d/drug information/13247.html" rel="external">acyclovir</a> therapy during pregnancy. Although suppressive therapy markedly reduces the risk of asymptomatic shedding, it does not completely eliminate it. Neonates with perinatal exposure to HSV (particularly maternal active genital lesions, but also postnatal direct exposure to individuals with active HSV oral lesions) should be monitored for evidence of HSV infection  (<a class="graphic graphic_algorithm graphicRef106124" href="/d/graphic/106124.html" rel="external">algorithm 1</a>). (See  <a class="medical medical_review" href="/d/html/6040.html" rel="external">"Neonatal herpes simplex virus infection: Management and prevention", section on 'Management of asymptomatic exposed infants'</a>.)</p><p class="headingAnchor" id="H67759361"><span class="h2">Detection of HSV</span><span class="headingEndMark"> — </span>The laboratory diagnosis of neonatal HSV infection may be established through isolation of HSV in traditional or enhanced viral culture, detection of viral DNA using qualitative or quantitative polymerase chain reaction (PCR) assays, and detection of viral antigens using rapid direct immunofluorescence assays (DFA). Serology is generally not helpful in the diagnosis of neonatal HSV at the time of presentation.</p><p class="headingAnchor" id="H67760522"><span class="h3">Specimens to collect</span><span class="headingEndMark"> — </span>Neonates with suspected HSV disease should have <strong>all</strong> of the following specimens obtained to evaluate for HSV infection [<a href="#rid31">31</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surface swabs</strong> – Swab specimens should be collected from the conjunctivae, mouth, nasopharynx, and rectum. Some experts suggest obtaining these with a single swab, starting with eyes and ending with the rectum, and placed in one viral transport media tube. Alternatively, they may be collected with multiple swabs and processed separately or placed in a single viral transport media tube and processed together. Regardless of how the specimens are collected, they should be tested with PCR and viral culture. (See <a class="local">'Skin and mucous membrane'</a> below and <a class="local">'Viral culture'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Swabs/scrapings of skin lesions</strong> – If the neonate has lesions on the skin or mucous membranes, swabs/scrapings/aspirate of vesicle fluid should be obtained and tested with PCR and viral culture. DFA of skin lesion scrapings may permit rapid detection of HSV; however, DFA is not as sensitive as culture or PCR. (See <a class="local">'Skin and mucous membrane'</a> below and <a class="local">'Viral culture'</a> below and <a class="local">'DFA and EIA'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>CSF</strong> – All neonates with suspected HSV, even infants who appear to have isolated skin, eye, and mouth (SEM) disease, should undergo lumbar puncture because clinical findings may be absent early in the course of CNS disease. PCR is the test of choice for detection of CNS involvement. (See <a class="local">'Cerebrospinal fluid'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Blood or plasma</strong> – Neonates with suspected HSV disease, of any classification, should have a whole blood or plasma sample tested for HSV using PCR. (See <a class="local">'Blood'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other specimens</strong> – Viral culture or HSV PCR should be performed on other specimens that are readily available (eg, tracheal aspirates in intubated infants, peritoneal fluid in neonates undergoing peritoneal drainage or laparotomy for other reasons). (See <a class="local">'Viral culture'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Additional studies</strong> – Additional testing should be performed to assess the degree of organ involvement, as discussed below. (See <a class="local">'Additional studies'</a> below.)</p><p></p><p class="headingAnchor" id="H15"><span class="h3">Viral culture</span><span class="headingEndMark"> — </span>Isolation of HSV by viral cell culture and serotyping HSV-1 or HSV-2 was traditionally the standard for definitive diagnosis of neonatal HSV infection. However, in the current era, many diagnostic virology laboratories and clinical reference laboratories offer PCR assays, which are an accurate and rapid method for detection and diagnosis of HSV infection. (See <a class="local">'Polymerase chain reaction'</a> below.)</p><p>Surface cultures (ie, from skin lesions, conjunctivae, mouth, nasopharynx, and rectum) are positive in ≥90 percent of cases and provide the greatest diagnostic yield of all methods to detect HSV, regardless of disease classification [<a href="#rid30">30</a>]. Isolation of HSV from surface sites of the neonate obtained &gt;12 to 24 hours after birth indicate viral replication and are suggestive of infection, rather than contamination from intrapartum exposure. This is the most common and noninvasive method to obtain evidence of active neonatal HSV infection [<a href="#rid1">1,31</a>].</p><p>Isolation of HSV by viral culture of other specimens (eg, CSF, blood, tracheal aspirates, duodenal aspirates, peritoneal fluid in neonates with ascites) can also establish the diagnosis, but these are less commonly performed. For CSF and blood samples, PCR is preferred over viral culture because it has greater sensitivity. The sensitivity of viral culture for detecting CNS involvement is low (approximately 25 to 40 percent) [<a href="#rid45">45</a>]. (See <a class="local">'Cerebrospinal fluid'</a> below and <a class="local">'Blood'</a> below.)</p><p>HSV grows readily on most cell lines used in clinical diagnostic virology laboratories. Evidence of viral cytopathic effect  (<a class="graphic graphic_picture graphicRef81175" href="/d/graphic/81175.html" rel="external">picture 1</a>) is usually evident under light microscopy in one to three days. Fresh vesicular lesions of the skin often are positive within 24 hours of incubation, whereas isolation from CSF or other sites may require several days. Viral cultures that remain negative at 10 days usually remain negative. HSV isolated in cell culture can be quickly and reliably typed as HSV-1 or HSV-2 using commercially available type-specific immunofluorescence assay reagents.</p><p>Twenty-four-hour cell culture enhancement systems, such as shell vial centrifugation fluorescent foci cultures (SVC) and enzyme-linked virus inducible systems (ELVIS), are used in many clinical laboratories and provide rapid detection of HSV in clinical systems within 24 to 48 hours [<a href="#rid46">46,47</a>]. The performance of these systems is generally comparable to cell culture in detecting HSV in skin and mucous membrane lesions, but not all these assays are able to distinguish and type HSV-1 or HSV-2.</p><p class="headingAnchor" id="H3170271138"><span class="h3">Polymerase chain reaction</span></p><p class="headingAnchor" id="H3619783272"><span class="h4">Cerebrospinal fluid</span><span class="headingEndMark"> — </span>PCR is the test of choice for detection of CNS involvement and has a sensitivity of 75 to 100 percent and specificity 71 to 100 percent [<a href="#rid45">45</a>]. The detection of HSV DNA in the CSF of a neonate confirms the diagnosis of CNS involvement. CSF HSV PCR is more sensitive than viral culture; however, blood or high protein in the CSF may interfere with some PCR assays and produce false negative results [<a href="#rid48">48-53</a>]. False negative results have also been reported with CSF specimens obtained early in the course of illness and samples obtained several days into antiviral therapy [<a href="#rid1">1,48,50,53</a>]. If the initial CSF HSV PCR is negative, yet neonatal HSV CNS disease is strongly suspected, the CSF PCR should be repeated during the first week of illness [<a href="#rid54">54</a>]. In neonates with evidence of CNS involvement, such as seizures, focal neurologic signs, abnormal CSF, or abnormal brain imaging, the detection of HSV DNA confirms the diagnosis of HSV meningoencephalitis. However, neonates may have CNS HSV infection without overt clinical, laboratory, or imaging signs of meningoencephalitis. Approximately 25 percent of neonates with HSV apparently localized to the SEM, and more than 90 percent of neonates with disseminated HSV disease, have HSV DNA detected in their CSF by PCR [<a href="#rid1">1</a>]. Thus, it is imperative to include a CSF examination and CSF HSV PCR in all neonates with suspected or proven neonatal HSV infection.</p><p>Quantitative HSV PCR can be performed on CSF samples, but studies have not confirmed that the level of HSV DNA by PCR correlates with neurologic outcomes [<a href="#rid55">55</a>].</p><p class="headingAnchor" id="H6571346"><span class="h4">Blood</span><span class="headingEndMark"> — </span>In neonates with signs and symptoms of disseminated HSV disease, detection of HSV DNA in the blood or plasma confirms the diagnosis and provides the opportunity for early initiation of antiviral therapy [<a href="#rid1">1,14,43,52,55,56</a>]. Results may differ somewhat depending on the sample type (whole blood versus plasma) and type of assay (qualitative versus quantitative). </p><p>Quantitative HSV PCR, if available, can be useful for several reasons:</p><p class="bulletIndent1"><span class="glyph">●</span>It may detect HSV infection</p><p class="bulletIndent1"><span class="glyph">●</span>It distinguishes the viral type (HSV-1 versus HSV-2)</p><p class="bulletIndent1"><span class="glyph">●</span>It quantifies the level of HSV viremia, which correlates with disease severity [<a href="#rid55">55</a>] </p><p></p><p>In a study of 63 infants treated for neonatal HSV at a single institution (1993 to 2012), plasma HSV PCR was positive in 78 percent of neonates with SEM, 64 percent with CNS disease, and 100 percent with disseminated disease [<a href="#rid55">55</a>]. Quantitative plasma HSV PCR levels were highest in infants with disseminated disease and levels &gt;7 log<sub>10</sub> copies/mL were associated with an increased risk of death.</p><p class="headingAnchor" id="H2231797113"><span class="h4">Skin and mucous membrane</span><span class="headingEndMark"> — </span>Many hospital-based and reference laboratories offer validated HSV PCR assays for skin and mucous membrane surface samples (ie, from skin lesions, conjunctivae, mouth, nasopharynx, and rectum). PCR assays on mucosal specimens, including multisource surface swabs, are an accurate and rapid method to detect HSV-1 or HSV-2 in neonates [<a href="#rid31">31,57,58</a>]. </p><p class="headingAnchor" id="H6571353"><span class="h4">Other sites</span><span class="headingEndMark"> — </span>PCR testing of other samples may be helpful in certain circumstances:</p><p class="bulletIndent1"><span class="glyph">●</span>In intubated patients, detection of HSV DNA in tracheal aspirates can help support a diagnosis of HSV pneumonitis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Detection of HSV DNA in amniotic fluid is diagnostic of in utero or congenital HSV.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In neonates with necrotizing enterocolitis managed with peritoneal drainage or laparotomy, detection of HSV DNA in peritoneal fluid provides evidence of HSV disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Detection of HSV DNA in the eye or conjunctivae may help establish the diagnosis of neonatal blepharoconjunctivitis or keratitis due to HSV, particularly in neonates in whom pretreatment with antiviral ophthalmic drops or systemic therapy may influence the viral culture results.</p><p></p><p class="headingAnchor" id="H17"><span class="h3">DFA and EIA</span><span class="headingEndMark"> — </span>DFA and enzyme immunoassays (EIA) methods permit rapid detection of HSV antigens in skin and mucous membrane lesions [<a href="#rid47">47,59</a>]. DFA has high specificity for HSV infection, and typing of the HSV antigens may be done directly on material on the slide. However, DFA is not as sensitive as PCR since the accuracy of DFA depends on the adequacy of the specimen (ie, it must contain sufficient cells) and the skill of the technician [<a href="#rid59">59</a>].</p><p>EIA is primarily used to screen asymptomatic or pregnant people for HSV genital infection [<a href="#rid59">59</a>]. Use of rapid EIA for diagnosis of neonatal HSV infection is <strong>not</strong> recommended since its performance in this setting is not well established.</p><p class="headingAnchor" id="H18"><span class="h3">Serology</span><span class="headingEndMark"> — </span>Serologic tests generally are <strong>not</strong> helpful in the diagnosis of neonatal HSV infection but may be used in the following circumstances:</p><p class="bulletIndent1"><span class="glyph">●</span>To identify HSV-2 infection in pregnant people so that steps can be taken to prevent neonatal infection. (See  <a class="medical medical_review" href="/d/html/8340.html" rel="external">"Genital herpes simplex virus infection and pregnancy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>To confirm the diagnosis of neonatal HSV infection when there is diagnostic uncertainty during the newborn period. Persistence of HSV type-specific immunoglobulin G (IgG) antibody beyond the time period of transplacental IgG antibody duration (ie, beyond six months) can help confirm the diagnosis if direct detection of the virus at the time of illness was not successful or possible. </p><p></p><p class="headingAnchor" id="H67759832"><span class="h3">Interpretation/diagnosis</span><span class="headingEndMark"> — </span>Interpretation of diagnostic testing for HSV in neonates depends upon the clinical circumstances  (<a class="graphic graphic_table graphicRef106132" href="/d/graphic/106132.html" rel="external">table 1</a>). Most infected infants have positive viral culture and/or PCR in one or more of the specimens listed above. (See <a class="local">'Specimens to collect'</a> above.)</p><p>Similarly, infants with negative viral culture/PCR in <strong>all</strong> of the above listed specimens are unlikely to be infected with HSV. However, in the setting of highly suggestive clinical, laboratory, or radiologic findings, negative results do not exclude HSV infection.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>SEM disease</strong> – The diagnosis of SEM disease is based upon the following clinical and laboratory parameters:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Localized skin disease with the characteristic vesicular lesions  (<a class="graphic graphic_picture graphicRef75059" href="/d/graphic/75059.html" rel="external">picture 5C</a> and <a class="graphic graphic_picture graphicRef56041" href="/d/graphic/56041.html" rel="external">picture 5B</a>); eye involvement; and/or localized ulcerative lesions of the mouth, palate, and tongue, <strong>and</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Absence of CNS disease (including negative CSF HSV PCR) or other organ system involvement, <strong>and</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>One or more of the following:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Detection of HSV by viral culture, PCR, or DFA in surface swabs or skin lesion swabs/scraping collected &gt;12 to 24 hours after birth (present in &gt;90 percent)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Positive HSV DNA PCR in the blood or plasma (present in 75 to 80 percent and does not necessarily signify disseminated disease if there are no signs of systemic illness or end organ involvement)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>CNS disease</strong> – The diagnosis of CNS disease is based upon the following clinical, laboratory, and radiographic parameters:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Positive CSF HSV DNA PCR (present in 75 to 100 percent; if the initial CSF HSV PCR is negative, yet neonatal HSV CNS disease is strongly suspected, the CSF PCR may be repeated during the first week of illness)</p><p></p><p class="bulletIndent2"><strong>or</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Clinical evidence of CNS involvement (eg, seizures, abnormal neurologic examination, abnormal EEG, and/or abnormal neuroimaging), <strong>and</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Either or both of the following:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Detection of HSV by viral culture, PCR, or DFA in surface swabs or skin lesion swab/scraping collected &gt;12 to 24 hours after birth (present in &gt;90 percent)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Positive HSV DNA PCR in the blood or plasma (present in approximately 65 percent)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disseminated disease</strong> – The diagnosis of disseminated disease is based upon the following clinical, laboratory, and radiographic parameters:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Clinical signs of systemic involvement (eg, severe sepsis syndrome, hepatitis, pneumonia, disseminated intravascular coagulation, and/or thrombocytopenia), <strong>and</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>One or more of the following:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Detection of HSV by viral culture, PCR, or DFA in surface swabs or skin lesion swabs/scraping collected &gt;12 to 24 hours after birth (present in &gt;90 percent of neonates with SEM disease)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Positive HSV DNA PCR in the blood or plasma (present in nearly all cases)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Positive CSF HSV DNA PCR (present in up to 90 percent)</p><p></p><p class="headingAnchor" id="H67759355"><span class="h2">Additional studies</span><span class="headingEndMark"> — </span>A comprehensive evaluation should be performed in all neonates with suspected or proven HSV disease. This evaluation is necessary, even in infants who appear to have isolated SEM disease because clinical findings may be absent early in the course of CNS and disseminated disease. In addition to routine laboratory tests, ophthalmologic examination and neuroimaging should be performed in all infants with virologically confirmed HSV infection, and EEG should be performed in neonates with CNS involvement [<a href="#rid1">1,32</a>]. (See <a class="local">'Electroencephalogram'</a> below and <a class="local">'Diagnostic imaging'</a> below.)</p><p class="headingAnchor" id="H67759205"><span class="h3">Laboratory evaluation</span><span class="headingEndMark"> — </span>Laboratory evaluation in neonates with suspected or proven HSV disease includes all of the following tests which determine the degree of organ involvement and exclude other diseases that may cause similar clinical symptoms [<a href="#rid1">1,14,31,43</a>] (see <a class="local">'Differential diagnosis'</a> below):</p><p class="bulletIndent1"><span class="glyph">●</span>Complete blood count, including differential and platelet count.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Liver transaminases, total and direct bilirubin, ammonia (ammonia should be performed to exclude liver failure and metabolic disease in neonates with elevated liver enzymes and fulminant sepsis but is not necessary for all neonates with suspected HSV).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Blood urea nitrogen (BUN), creatinine, and urinalysis (to assess renal function and hydration status).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CSF cell count, glucose, and protein.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Blood and CSF cultures to evaluate for possible bacterial sepsis (most neonates with neonatal HSV disease have negative blood cultures; however, bacterial coinfections can occur, especially in neonates with liver and intestinal involvement, where gram-negative bacteremia, sepsis, or peritonitis may compound the clinical presentation of neonatal HSV). (See  <a class="medical medical_review" href="/d/html/5043.html" rel="external">"Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates"</a> and  <a class="medical medical_review" href="/d/html/6005.html" rel="external">"Bacterial meningitis in the neonate: Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation for metabolic disease as indicated by the clinical scenario. (See  <a class="medical medical_review" href="/d/html/2936.html" rel="external">"Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features"</a> and  <a class="medical medical_review" href="/d/html/2912.html" rel="external">"Metabolic emergencies in suspected inborn errors of metabolism: Presentation, evaluation, and management"</a>.)</p><p></p><p class="headingAnchor" id="H2124036627"><span class="h3">Eye examination</span><span class="headingEndMark"> — </span>All infants with neonatal HSV disease, regardless of disease classification, should have an ophthalmologic examination in addition to conjunctival HSV cultures to evaluate for eye involvement [<a href="#rid31">31</a>].</p><p class="headingAnchor" id="H19"><span class="h3">Electroencephalogram</span><span class="headingEndMark"> — </span>EEG should be performed in all neonates suspected to have CNS involvement, particularly those with seizures, abnormal movements suspicious for seizures, or abnormal CSF.</p><p>EEG is highly sensitive for neonatal HSV infection with CNS involvement and often is abnormal before CT or MRI. An abnormal EEG with lateralized periodic discharges (LPDs; formerly called periodic lateralized epileptiform discharges [PLEDS]) is a characteristic finding in neonatal HSV encephalitis [<a href="#rid34">34</a>]. However, LPDs are nonspecific and can be seen in other types of brain injury.</p><p class="headingAnchor" id="H20"><span class="h3">Diagnostic imaging</span></p><p class="headingAnchor" id="H21"><span class="h4">Brain imaging</span><span class="headingEndMark"> — </span>All infants with neonatal HSV disease, regardless of disease classification, should have neuroimaging with MRI, CT, or ultrasonography [<a href="#rid31">31</a>]. In neonates with suspected or proven CNS involvement, brain imaging with enhanced CT or MRI is recommended to determine the location and extent of brain involvement [<a href="#rid1">1,32</a>]. Contrast-enhanced MRI with diffusion-weighted imaging (DWI) is preferred over CT or noncontrast MRI because it is more sensitive than CT [<a href="#rid32">32</a>]. However, CT is acceptable if MRI cannot be readily performed. A normal CT or conventional MRI early in the course does not exclude HSV CNS involvement since subtle findings may only be detected with DWI. Head ultrasound should not be used as the sole imaging study in infants with clinical evidence of CNS disease since neonatal ultrasound often underrepresents the extent of brain involvement. However, prenatal ultrasound may show fetal brain damage in intrauterine HSV disease.  </p><p>The imaging findings of neonatal HSV CNS disease are variable. Neuroimaging may be normal early in the course of CNS disease. Several days to a week into illness, neuroimaging may show parenchymal brain edema or abnormal attenuation, hemorrhage, or destructive lesions  (<a class="graphic graphic_diagnosticimage graphicRef64607" href="/d/graphic/64607.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef106590" href="/d/graphic/106590.html" rel="external">image 2</a>) [<a href="#rid1">1,32</a>]. In addition to the classic temporal lobe destructive lesions, imaging abnormalities may be multifocal or limited to the brainstem or cerebellum [<a href="#rid34">34</a>]. Long-term sequelae of neonatal HSV CNS involvement includes atrophy and cystic encephalomalacia.</p><p class="headingAnchor" id="H22"><span class="h4">Chest radiograph</span><span class="headingEndMark"> — </span>Chest radiographs should be obtained in infants with signs of pulmonary involvement. In neonates with lung involvement, chest radiographs may demonstrate bilateral, diffuse pneumonitis.</p><p class="headingAnchor" id="H23"><span class="h4">Abdominal ultrasonography</span><span class="headingEndMark"> — </span>Abdominal ultrasonography is not routinely required in the diagnostic evaluation. In neonates with HSV hepatitis and acute liver failure, ultrasonography may demonstrate liver enlargement, ascites, or complex fluid collections consistent with peritonitis.</p><p class="headingAnchor" id="H20791466"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of neonatal HSV is broad and includes infectious and noninfectious conditions that are associated with vesicular skin lesions, eye disease, central nervous system (CNS) manifestations, and/or systemic illness in neonates:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vesicular skin lesions</strong> – The differential diagnosis of vesicular skin lesions in neonates is reviewed separately. (See  <a class="medical medical_review" href="/d/html/5790.html" rel="external">"Vesicular, pustular, and bullous lesions in the newborn and infant"</a> and  <a class="medical medical_review" href="/d/html/119230.html" rel="external">"Skin lesions in the newborn and infant"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Eye disease:</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Viral conjunctivitis due to adenovirus or enterovirus (see  <a class="medical medical_review" href="/d/html/6907.html" rel="external">"Conjunctivitis", section on 'Viral conjunctivitis'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bacterial conjunctivitis (eg, <em>Chlamydia trachomatis</em>, <em>Neisseria gonorrhoeae</em>) (see  <a class="medical medical_review" href="/d/html/4993.html" rel="external">"Chlamydia trachomatis infections in the newborn", section on 'Conjunctivitis'</a> and  <a class="medical medical_review" href="/d/html/4983.html" rel="external">"Gonococcal infection in the newborn", section on 'Ophthalmia neonatorum'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Trauma (see  <a class="medical medical_review" href="/d/html/13904.html" rel="external">"Conjunctival injury"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>CNS disease:</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bacterial meningitis (see  <a class="medical medical_review" href="/d/html/6005.html" rel="external">"Bacterial meningitis in the neonate: Clinical features and diagnosis"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Viral meningoencephalitis (other than HSV), particularly enterovirus and parechovirus (see  <a class="medical medical_review" href="/d/html/5983.html" rel="external">"Viral meningitis in children: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/2693.html" rel="external">"Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Neonates'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>CNS insult (eg, anoxia, trauma, or hemorrhage) [<a href="#rid60">60</a>] (see  <a class="medical medical_review" href="/d/html/6216.html" rel="external">"Clinical features, diagnosis, and treatment of neonatal encephalopathy"</a> and  <a class="medical medical_review" href="/d/html/5051.html" rel="external">"Germinal matrix and intraventricular hemorrhage (GMH-IVH) in the newborn: Risk factors, clinical features, screening, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6610.html" rel="external">"Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Neonatal abstinence syndrome (see  <a class="medical medical_review" href="/d/html/5016.html" rel="external">"Prenatal substance exposure and neonatal abstinence syndrome (NAS): Management and outcomes"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Inborn errors of metabolism (see  <a class="medical medical_review" href="/d/html/2936.html" rel="external">"Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features"</a> and  <a class="medical medical_review" href="/d/html/2912.html" rel="external">"Metabolic emergencies in suspected inborn errors of metabolism: Presentation, evaluation, and management"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hypoglycemia (see  <a class="medical medical_review" href="/d/html/5053.html" rel="external">"Pathogenesis, screening, and diagnosis of neonatal hypoglycemia"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disseminated disease:</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bacterial sepsis (see  <a class="medical medical_review" href="/d/html/5043.html" rel="external">"Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Adenovirus (see  <a class="medical medical_review" href="/d/html/8339.html" rel="external">"Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection", section on 'Clinical presentation'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Enterovirus or parechovirus, particularly during the enteroviral season [<a href="#rid35">35</a>] (see  <a class="medical medical_review" href="/d/html/2693.html" rel="external">"Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Neonates'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Other neonatal infections, such as cytomegalovirus, toxoplasmosis, syphilis, and rubella (see  <a class="medical medical_review" href="/d/html/6011.html" rel="external">"Overview of TORCH infections"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Viral hepatitis (other than HSV), drug-induced hepatitis, or causes of neonatal liver disease (see  <a class="medical medical_review" href="/d/html/5941.html" rel="external">"Approach to evaluation of cholestasis in neonates and young infants"</a> and  <a class="medical medical_review" href="/d/html/16142.html" rel="external">"Acute liver failure in children: Etiology and evaluation"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Viral pneumonia, such as:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Respiratory syncytial virus (see  <a class="medical medical_review" href="/d/html/5994.html" rel="external">"Respiratory syncytial virus infection: Clinical features and diagnosis in infants and children"</a>)</p><p class="bulletIndent3"><span class="glyph">-</span>Adenovirus (see  <a class="medical medical_review" href="/d/html/8339.html" rel="external">"Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection"</a>)</p><p class="bulletIndent3"><span class="glyph">-</span>Influenza (see  <a class="medical medical_review" href="/d/html/5973.html" rel="external">"Seasonal influenza in children: Clinical features and diagnosis"</a>)</p><p class="bulletIndent3"><span class="glyph">-</span>Parainfluenza (see  <a class="medical medical_review" href="/d/html/5975.html" rel="external">"Parainfluenza viruses in children"</a>)</p><p class="bulletIndent3"><span class="glyph">-</span>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (see  <a class="medical medical_review" href="/d/html/127488.html" rel="external">"COVID-19: Clinical manifestations and diagnosis in children"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Inborn errors of metabolism (see  <a class="medical medical_review" href="/d/html/2936.html" rel="external">"Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features"</a> and  <a class="medical medical_review" href="/d/html/2912.html" rel="external">"Metabolic emergencies in suspected inborn errors of metabolism: Presentation, evaluation, and management"</a>)</p><p></p><p>Microbiologic studies (eg, cultures, polymerase chain reaction [PCR] tests) differentiate neonatal HSV from other infectious conditions. Review of the newborn screening results and/or consultation with a geneticist can be helpful to exclude inborn errors of metabolism. Noninfectious dermatologic conditions may have a characteristic clinical course (eg, transient neonatal pustular melanosis, incontinentia pigmenti). However, given increased morbidity and mortality of neonatal HSV disease, and the benefits of early treatment, empiric antiviral therapy for HSV is warranted (after appropriate microbiologic and virologic specimens are obtained) pending definitive diagnosis. (See  <a class="medical medical_review" href="/d/html/6040.html" rel="external">"Neonatal herpes simplex virus infection: Management and prevention", section on 'Initial antiviral therapy'</a>.)</p><p class="headingAnchor" id="H529455976"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/109959.html" rel="external">"Society guideline links: Infectious encephalitis"</a> and  <a class="medical medical_society_guidelines" href="/d/html/111578.html" rel="external">"Society guideline links: TORCH infections"</a>.)</p><p class="headingAnchor" id="H24"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Neonatal herpes simplex virus (HSV) infection occurs in approximately 1 in 3200 to 10,000 live births. Neonatal HSV may be acquired in utero (congenital HSV), perinatally (approximately 85 percent of cases), or postnatally (approximately 10 percent of cases). (See <a class="local">'Epidemiology and transmission'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intrauterine infection</strong> – Intrauterine HSV is associated with hydrops fetalis and fetal in utero demise. Survivors may exhibit a characteristic triad of skin vesicles or scarring, eye damage, and severe central nervous system (CNS) manifestations including microcephaly, cystic encephalomalacia, or hydranencephaly. (See <a class="local">'Intrauterine HSV'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neonatal HSV</strong> – Perinatally and postnatally acquired neonatal HSV may be classified into three main categories for therapeutic and prognostic purposes  (<a class="graphic graphic_table graphicRef106132" href="/d/graphic/106132.html" rel="external">table 1</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Localized SEM disease</strong> is characterized by coalescing or clustering vesicular lesions of the skin  (<a class="graphic graphic_picture graphicRef75059" href="/d/graphic/75059.html" rel="external">picture 5C</a> and <a class="graphic graphic_picture graphicRef56041" href="/d/graphic/56041.html" rel="external">picture 5B</a>); excessive tearing, eye pain, conjunctival edema; and/or localized ulcerative lesions of the mouth, palate, and tongue.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>CNS disease</strong>, which may be manifested by seizures (focal or generalized), lethargy, irritability, tremors, poor feeding, temperature instability (fever or hypothermia), and full anterior fontanel. (See <a class="local">'Central nervous system disease'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Disseminated disease</strong>, which involves multiple organs. Neonates with disseminated HSV often present in the first week of life with nonspecific signs and symptoms of neonatal sepsis (eg, temperature dysregulation, apnea, irritability, lethargy, respiratory distress, abdominal distension, hepatomegaly, ascites). The mortality of untreated disseminated neonatal HSV exceeds 80 percent. (See <a class="local">'Disseminated disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical suspicion</strong> – Neonatal HSV infection should be suspected in neonates with any of the following (see <a class="local">'Clinical suspicion'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mucocutaneous lesions  (<a class="graphic graphic_picture graphicRef75059" href="/d/graphic/75059.html" rel="external">picture 5C</a> and <a class="graphic graphic_picture graphicRef56041" href="/d/graphic/56041.html" rel="external">picture 5B</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Abnormal CNS findings (cerebrospinal fluid [CSF] pleocytosis, seizures, focal neurologic signs, abnormal neuroimaging  (<a class="graphic graphic_diagnosticimage graphicRef64607" href="/d/graphic/64607.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef106590" href="/d/graphic/106590.html" rel="external">image 2</a>)), or</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sepsis-like illness (respiratory distress, apnea, abdominal distension, ascites, hepatomegaly, progressive pneumonitis, temperature dysregulation, hepatitis, thrombocytopenia, coagulopathy)</p><p></p><p class="bulletIndent1">In addition, neonates with perinatal exposure to HSV (eg, maternal active genital lesions) should be monitored for evidence of HSV infection, as summarized in the figure  (<a class="graphic graphic_algorithm graphicRef106124" href="/d/graphic/106124.html" rel="external">algorithm 1</a>), and discussed in detail separately. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic evaluation</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Virologic testing</strong> – The diagnosis of neonatal HSV infection may be established through isolation of HSV in culture, detection of HSV DNA using qualitative or quantitative polymerase chain reaction (PCR) assays, and/or detection of HSV antigens using direct immunofluorescence assays (DFA). Neonates with suspected HSV infection should have <strong>all</strong> of the following tests performed (see <a class="local">'Detection of HSV'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Viral culture or HSV PCR on surface swabs of the conjunctivae, mouth, nasopharynx, and rectum</p><p class="bulletIndent3"><span class="glyph">-</span>Viral culture or HSV PCR (with or without DFA) of swabs/scrapings of any skin and mucous membrane lesions</p><p class="bulletIndent3"><span class="glyph">-</span>CSF HSV PCR</p><p class="bulletIndent3"><span class="glyph">-</span>Whole blood or plasma HSV PCR</p><p class="bulletIndent3"><span class="glyph">-</span>Viral culture or HSV PCR of tracheal aspirate if intubated</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Interpretation</strong> – Interpretation of diagnostic testing for HSV in neonates depends upon the clinical circumstances  (<a class="graphic graphic_table graphicRef106132" href="/d/graphic/106132.html" rel="external">table 1</a>). Most infected infants have positive viral culture and/or PCR in one or more of the specimens listed above. Similarly, infants with negative viral culture/PCR in <strong>all</strong> of the above listed specimens are unlikely to be infected with HSV. However, in the setting of highly suggestive clinical, laboratory, or radiologic findings, negative results do not exclude HSV infection. (See <a class="local">'Interpretation/diagnosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Additional evaluation in confirmed cases</strong> – A comprehensive evaluation should be performed in all neonates with confirmed HSV infection to determine the degree of organ involvement. This includes (see <a class="local">'Additional studies'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Complete blood count, including differential and platelet count</p><p class="bulletIndent3"><span class="glyph">-</span>Liver transaminases, total and direct bilirubin</p><p class="bulletIndent3"><span class="glyph">-</span>Blood urea nitrogen (BUN), creatinine, and urinalysis</p><p class="bulletIndent3"><span class="glyph">-</span>Lumbar puncture (if not already done)</p><p class="bulletIndent3"><span class="glyph">-</span>Ophthalmologic examination</p><p class="bulletIndent3"><span class="glyph">-</span>Neuroimaging</p><p class="bulletIndent3"><span class="glyph">-</span>EEG, if there is other evidence of CNS involvement (eg, seizures, abnormal neurologic examination)</p><p class="bulletIndent3"><span class="glyph">-</span>Chest radiograph if there are pulmonary findings</p><p></p><p class="bulletIndent2">This evaluation is necessary, even in infants who appear to have isolated SEM disease, because clinical findings may be absent early in the course of CNS and disseminated disease.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Differential diagnosis</strong> – The differential diagnosis of neonatal HSV is broad and includes infectious and noninfectious conditions that are associated with vesicular skin lesions, eye disease, CNS manifestations, and/or systemic illness in neonates. Pending definitive diagnosis, empiric therapy for neonatal HSV may be warranted (after appropriate microbiologic and virologic specimens are obtained). (See <a class="local">'Differential diagnosis'</a> above and  <a class="medical medical_review" href="/d/html/6040.html" rel="external">"Neonatal herpes simplex virus infection: Management and prevention", section on 'Initial antiviral therapy'</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev 2004; 17:1.</a></li><li><a class="nounderline abstract_t">Akhtar LN, Bowen CD, Renner DW, et al. Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population. mSphere 2019; 4.</a></li><li><a class="nounderline abstract_t">Flagg EW, Weinstock H. Incidence of neonatal herpes simplex virus infections in the United States, 2006. Pediatrics 2011; 127:e1.</a></li><li><a class="nounderline abstract_t">Mahnert N, Roberts SW, Laibl VR, et al. The incidence of neonatal herpes infection. Am J Obstet Gynecol 2007; 196:e55.</a></li><li><a class="nounderline abstract_t">Batra D, Davies P, Manktelow BN, Smith C. The incidence and presentation of neonatal herpes in a single UK tertiary centre, 2006-2013. Arch Dis Child 2014; 99:916.</a></li><li><a class="nounderline abstract_t">Jones CA, Raynes-Greenow C, Isaacs D, Neonatal HSV Study Investigators and Contributors to the Australian Paediatric Surveillance Unit. Population-based surveillance of neonatal herpes simplex virus infection in Australia, 1997-2011. Clin Infect Dis 2014; 59:525.</a></li><li><a class="nounderline abstract_t">Mahant S, Hall M, Schondelmeyer AC, et al. Neonatal Herpes Simplex Virus Infection Among Medicaid-Enrolled Children: 2009-2015. Pediatrics 2019; 143.</a></li><li><a class="nounderline abstract_t">Donda K, Sharma M, Amponsah JK, et al. Trends in the incidence, mortality, and cost of neonatal herpes simplex virus hospitalizations in the United States from 2003 to 2014. J Perinatol 2019; 39:697.</a></li><li><a class="nounderline abstract_t">Melvin AJ, Mohan KM, Vora SB, et al. Neonatal Herpes Simplex Virus Infection: Epidemiology and Outcomes in the Modern Era. J Pediatric Infect Dis Soc 2022; 11:94.</a></li><li><a class="nounderline abstract_t">Cruz AT, Freedman SB, Kulik DM, et al. Herpes Simplex Virus Infection in Infants Undergoing Meningitis Evaluation. Pediatrics 2018; 141.</a></li><li><a class="nounderline abstract_t">Durukan D, Fairley CK, Bradshaw CS, et al. Increasing proportion of herpes simplex virus type 1 among women and men diagnosed with first-episode anogenital herpes: a retrospective observational study over 14 years in Melbourne, Australia. Sex Transm Infect 2019; 95:307.</a></li><li><a class="nounderline abstract_t">Kimberlin DW. Herpes simplex virus infections of the newborn. Semin Perinatol 2007; 31:19.</a></li><li><a class="nounderline abstract_t">Corey L, Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med 2009; 361:1376.</a></li><li><a class="nounderline abstract_t">Caviness AC, Demmler GJ, Selwyn BJ. Clinical and laboratory features of neonatal herpes simplex virus infection: a case-control study. Pediatr Infect Dis J 2008; 27:425.</a></li><li><a class="nounderline abstract_t">Whitley R, Arvin A, Prober C, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991; 324:450.</a></li><li><a class="nounderline abstract_t">O'Riordan DP, Golden WC, Aucott SW. Herpes simplex virus infections in preterm infants. Pediatrics 2006; 118:e1612.</a></li><li><a class="nounderline abstract_t">Stanberry LR. Neonatal herpes in premature infants: a special problem. Pediatrics 2006; 118:2543.</a></li><li><a class="nounderline abstract_t">Fidler KJ, Pierce CM, Cubitt WD, et al. Could neonatal disseminated herpes simplex virus infections be treated earlier? J Infect 2004; 49:141.</a></li><li><a class="nounderline abstract_t">Knezevic A, Martic J, Stanojevic M, et al. Disseminated neonatal herpes caused by herpes simplex virus types 1 and 2. Emerg Infect Dis 2007; 13:302.</a></li><li><a class="nounderline abstract_t">Pittet LF, Curtis N. Postnatal Exposure to Herpes Simplex Virus: To Treat or Not to Treat? Pediatr Infect Dis J 2021; 40:S16.</a></li><li><a class="nounderline abstract_t">Leas BF, Umscheid CA. Neonatal Herpes Simplex Virus Type 1 Infection and Jewish Ritual Circumcision With Oral Suction: A Systematic Review. J Pediatric Infect Dis Soc 2015; 4:126.</a></li><li><a class="nounderline abstract_t">Malik AN, Hildebrand GD, Sekhri R, Russell-Eggitt IM. Bilateral macular scars following intrauterine herpes simplex virus type 2 infection. J AAPOS 2008; 12:305.</a></li><li><a class="nounderline abstract_t">Koch LH, Fisher RG, Chen C, et al. Congenital herpes simplex virus infection: two unique cutaneous presentations associated with probable intrauterine transmission. J Am Acad Dermatol 2009; 60:312.</a></li><li><a class="nounderline abstract_t">Vasileiadis GT, Roukema HW, Romano W, et al. Intrauterine herpes simplex infection. Am J Perinatol 2003; 20:55.</a></li><li><a class="nounderline abstract_t">Marquez L, Levy ML, Munoz FM, Palazzi DL. A report of three cases and review of intrauterine herpes simplex virus infection. Pediatr Infect Dis J 2011; 30:153.</a></li><li><a class="nounderline abstract_t">Hyde SR, Giacoia GP. Congenital herpes infection: placental and umbilical cord findings. Obstet Gynecol 1993; 81:852.</a></li><li><a class="nounderline abstract_t">Peng J, Krause PJ, Kresch M. Neonatal herpes simplex virus infection after cesarean section with intact amniotic membranes. J Perinatol 1996; 16:397.</a></li><li><a class="nounderline abstract_t">Andersen RD. Herpes simplex virus infection of the neonatal respiratory tract. Am J Dis Child 1987; 141:274.</a></li><li><a class="nounderline abstract_t">Mascola L, Cable DC, Walsh P, Guinan ME. Neonatal herpes simplex virus death manifested as rapidly progressive pneumonia. Clin Pediatr (Phila) 1984; 23:400.</a></li><li><a class="nounderline abstract_t">Kimberlin DW, Lin CY, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001; 108:223.</a></li><li class="breakAll">American Academy of Pediatrics. Herpes simplex. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.407.</li><li><a class="nounderline abstract_t">Toth C, Harder S, Yager J. Neonatal herpes encephalitis: a case series and review of clinical presentation. Can J Neurol Sci 2003; 30:36.</a></li><li><a class="nounderline abstract_t">Corey L, Whitley RJ, Stone EF, Mohan K. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet 1988; 1:1.</a></li><li><a class="nounderline abstract_t">Mizrahi EM, Tharp BR. A characteristic EEG pattern in neonatal herpes simplex encephalitis. Neurology 1982; 32:1215.</a></li><li><a class="nounderline abstract_t">Caviness AC, Demmler GJ, Almendarez Y, Selwyn BJ. The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates. J Pediatr 2008; 153:164.</a></li><li><a class="nounderline abstract_t">Long SS. In defense of empiric acyclovir therapy in certain neonates. J Pediatr 2008; 153:157.</a></li><li><a class="nounderline abstract_t">Kimberlin DW. When should you initiate acyclovir therapy in a neonate? J Pediatr 2008; 153:155.</a></li><li><a class="nounderline abstract_t">Manglani M, Poley M, Kumar A, et al. Anti-NMDAR Encephalitis After Neonatal HSV-1 Infection in a Child With Low TLR-3 Function. Pediatrics 2021; 148.</a></li><li><a class="nounderline abstract_t">Riediger C, Sauer P, Matevossian E, et al. Herpes simplex virus sepsis and acute liver failure. Clin Transplant 2009; 23 Suppl 21:37.</a></li><li><a class="nounderline abstract_t">Meyer TA, Warner BW. Extracorporeal life support for the treatment of viral pneumonia: collective experience from the ELSO registry. Extracorporeal Life Support Organization. J Pediatr Surg 1997; 32:232.</a></li><li><a class="nounderline abstract_t">Filippine MM, Katz BZ. Neonatal herpes simplex virus infection presenting with fever alone. J Hum Virol 2001; 4:223.</a></li><li><a class="nounderline abstract_t">Davis KL, Shah SS, Frank G, Eppes SC. Why are young infants tested for herpes simplex virus? Pediatr Emerg Care 2008; 24:673.</a></li><li><a class="nounderline abstract_t">Cantey JB, Mejías A, Wallihan R, et al. Use of blood polymerase chain reaction testing for diagnosis of herpes simplex virus infection. J Pediatr 2012; 161:357.</a></li><li><a class="nounderline abstract_t">Caviness AC, Demmler GJ, Swint JM, Cantor SB. Cost-effectiveness analysis of herpes simplex virus testing and treatment strategies in febrile neonates. Arch Pediatr Adolesc Med 2008; 162:665.</a></li><li class="breakAll">Kimberlin DW, Gutierrez KM. Herpes simplex virus infections. In: Remington and Klein's infectious diseases of the fetus and newborn infant, 8th, Wilson CB, Nizet V, Maldonado YA, Remington JS, Klein JO (Eds), Saunders, Phildelphia, PA 2016. p.843.</li><li><a class="nounderline abstract_t">LaRocco MT. Evaluation of an enzyme-linked viral inducible system for the rapid detection of Herpes simplex virus. Eur J Clin Microbiol Infect Dis 2000; 19:233.</a></li><li><a class="nounderline abstract_t">Verano L, Michalski FJ. Comparison of a direct antigen enzyme immunoassay, Herpchek, with cell culture for detection of herpes simplex virus from clinical specimens. J Clin Microbiol 1995; 33:1378.</a></li><li><a class="nounderline abstract_t">Espy MJ, Uhl JR, Mitchell PS, et al. Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR. J Clin Microbiol 2000; 38:795.</a></li><li><a class="nounderline abstract_t">Slomka MJ, Emery L, Munday PE, et al. A comparison of PCR with virus isolation and direct antigen detection for diagnosis and typing of genital herpes. J Med Virol 1998; 55:177.</a></li><li><a class="nounderline abstract_t">Kimberlin DW, Lakeman FD, Arvin AM, et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1996; 174:1162.</a></li><li><a class="nounderline abstract_t">Malm G, Forsgren M. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum. Arch Dis Child Fetal Neonatal Ed 1999; 81:F24.</a></li><li><a class="nounderline abstract_t">Kimura H, Futamura M, Kito H, et al. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J Infect Dis 1991; 164:289.</a></li><li><a class="nounderline abstract_t">Troendle-Atkins J, Demmler GJ, Buffone GJ. Rapid diagnosis of herpes simplex virus encephalitis by using the polymerase chain reaction. J Pediatr 1993; 123:376.</a></li><li><a class="nounderline abstract_t">Frenkel LM. Challenges in the diagnosis and management of neonatal herpes simplex virus encephalitis. Pediatrics 2005; 115:795.</a></li><li><a class="nounderline abstract_t">Melvin AJ, Mohan KM, Schiffer JT, et al. Plasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infection. J Pediatr 2015; 166:827.</a></li><li><a class="nounderline abstract_t">Mejías A, Bustos R, Ardura MI, et al. Persistence of herpes simplex virus DNA in cerebrospinal fluid of neonates with herpes simplex virus encephalitis. J Perinatol 2009; 29:290.</a></li><li><a class="nounderline abstract_t">Dominguez SR, Pretty K, Hengartner R, Robinson CC. Comparison of Herpes Simplex Virus PCR with Culture for Virus Detection in Multisource Surface Swab Specimens from Neonates. J Clin Microbiol 2018; 56.</a></li><li><a class="nounderline abstract_t">Schremser V, Antoniewicz L, Tschachler E, Geusau A. Polymerase chain reaction for the diagnosis of herpesvirus infections in dermatology : Analysis of clinical data. Wien Klin Wochenschr 2020; 132:35.</a></li><li><a class="nounderline abstract_t">Reina J, Saurina J, Fernandez-Baca V, et al. Evaluation of a direct immunofluorescence cytospin assay for the detection of herpes simplex virus in clinical samples. Eur J Clin Microbiol Infect Dis 1997; 16:851.</a></li><li><a class="nounderline abstract_t">Kurtz J, Anslow P. Infantile herpes simplex encephalitis: diagnostic features and differentiation from non-accidental injury. J Infect 2003; 46:12.</a></li></ol></div><div id="topicVersionRevision">Topic 6037 Version 36.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14726453" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Neonatal herpes simplex infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30814317" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21149432" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Incidence of neonatal herpes simplex virus infections in the United States, 2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17466681" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The incidence of neonatal herpes infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24919712" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The incidence and presentation of neonatal herpes in a single UK tertiary centre, 2006-2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24846638" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Population-based surveillance of neonatal herpes simplex virus infection in Australia, 1997-2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30923058" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Neonatal Herpes Simplex Virus Infection Among Medicaid-Enrolled Children: 2009-2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30911082" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Trends in the incidence, mortality, and cost of neonatal herpes simplex virus hospitalizations in the United States from 2003 to 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34894240" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Neonatal Herpes Simplex Virus Infection: Epidemiology and Outcomes in the Modern Era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29298827" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Herpes Simplex Virus Infection in Infants Undergoing Meningitis Evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30554143" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Increasing proportion of herpes simplex virus type 1 among women and men diagnosed with first-episode anogenital herpes: a retrospective observational study over 14 years in Melbourne, Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17317423" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Herpes simplex virus infections of the newborn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19797284" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Maternal and neonatal herpes simplex virus infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18360301" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Clinical and laboratory features of neonatal herpes simplex virus infection: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1988830" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17142491" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Herpes simplex virus infections in preterm infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17142540" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Neonatal herpes in premature infants: a special problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15236921" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Could neonatal disseminated herpes simplex virus infections be treated earlier?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17479897" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Disseminated neonatal herpes caused by herpes simplex virus types 1 and 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32773663" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Postnatal Exposure to Herpes Simplex Virus: To Treat or Not to Treat?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26407411" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Neonatal Herpes Simplex Virus Type 1 Infection and Jewish Ritual Circumcision With Oral Suction: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18440255" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Bilateral macular scars following intrauterine herpes simplex virus type 2 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19150274" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Congenital herpes simplex virus infection: two unique cutaneous presentations associated with probable intrauterine transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12660908" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Intrauterine herpes simplex infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20811312" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : A report of three cases and review of intrauterine herpes simplex virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8385765" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Congenital herpes infection: placental and umbilical cord findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8915941" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Neonatal herpes simplex virus infection after cesarean section with intact amniotic membranes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3028126" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Herpes simplex virus infection of the neonatal respiratory tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6723189" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Neonatal herpes simplex virus death manifested as rapidly progressive pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11483781" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Natural history of neonatal herpes simplex virus infections in the acyclovir era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11483781" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Natural history of neonatal herpes simplex virus infections in the acyclovir era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12619782" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Neonatal herpes encephalitis: a case series and review of clinical presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2891886" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6890154" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : A characteristic EEG pattern in neonatal herpes simplex encephalitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18534225" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18639725" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : In defense of empiric acyclovir therapy in certain neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18639724" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : When should you initiate acyclovir therapy in a neonate?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34385350" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Anti-NMDAR Encephalitis After Neonatal HSV-1 Infection in a Child With Low TLR-3 Function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19930315" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Herpes simplex virus sepsis and acute liver failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9044128" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Extracorporeal life support for the treatment of viral pneumonia: collective experience from the ELSO registry. Extracorporeal Life Support Organization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11694851" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Neonatal herpes simplex virus infection presenting with fever alone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19242136" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Why are young infants tested for herpes simplex virus?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22608699" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Use of blood polymerase chain reaction testing for diagnosis of herpes simplex virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18606938" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Cost-effectiveness analysis of herpes simplex virus testing and treatment strategies in febrile neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18606938" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Cost-effectiveness analysis of herpes simplex virus testing and treatment strategies in febrile neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10795600" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Evaluation of an enzyme-linked viral inducible system for the rapid detection of Herpes simplex virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7615760" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Comparison of a direct antigen enzyme immunoassay, Herpchek, with cell culture for detection of herpes simplex virus from clinical specimens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10655387" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9598940" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : A comparison of PCR with virus isolation and direct antigen detection for diagnosis and typing of genital herpes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8940204" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10375358" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1649876" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8394900" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Rapid diagnosis of herpes simplex virus encephalitis by using the polymerase chain reaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15741389" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Challenges in the diagnosis and management of neonatal herpes simplex virus encephalitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25491092" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Plasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19194454" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Persistence of herpes simplex virus DNA in cerebrospinal fluid of neonates with herpes simplex virus encephalitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29875197" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Comparison of Herpes Simplex Virus PCR with Culture for Virus Detection in Multisource Surface Swab Specimens from Neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31820101" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Polymerase chain reaction for the diagnosis of herpesvirus infections in dermatology : Analysis of clinical data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9447911" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Evaluation of a direct immunofluorescence cytospin assay for the detection of herpes simplex virus in clinical samples.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12504603" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Infantile herpes simplex encephalitis: diagnostic features and differentiation from non-accidental injury.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
